Figure 1From: Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)Patient disposition and study flow diagram of patients. *Patients who signed informed consent, but did not proceed to randomization or the nondrug-interventional arm.Back to article page